ArdorComm Media Group

Contact Us
logo
Menu
logo
ArdorComm ArdorComm ArdorComm

AI in healthcare

UAE Healthcare Sets Global Benchmark in Preventive Medicine: M42 CEO

Leave a Comment / By / Health & Wellness Community

Abu Dhabi, UAE: The UAE healthcare system has established itself as a global leader in preventive medicine, driven by cutting-edge technology, genomic research, and AI-powered healthcare solutions. Speaking to the Emirates News Agency (WAM), Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, highlighted the nation’s advancements underpinned by visionary leadership and collaborative innovation. Driving Healthcare Innovation Al Nowais credited the UAE’s leadership for fostering an ecosystem that integrates advanced hospitals, robotic technologies, genomic science, and artificial intelligence, enabling a shift from reactive treatment to proactive health management. He underscored M42’s collaboration with government entities to revolutionize healthcare by focusing on: Early detection of health risks through data-driven insights Delivering targeted treatments more efficiently Reducing healthcare costs while improving outcomes M42’s Vision for Preventive Care M42 is committed to shifting healthcare paradigms by prioritizing precision, preventive, and predictive medicine. The group also aims to enhance healthy ageing, promote general well-being, and transition to a more sustainable healthcare model. “For meaningful, lasting, and positive change that enhances human longevity worldwide, we must collectively focus on three pillars: precision, preventive, and predictive medicine,” Al Nowais stated, emphasizing the role of AI and genomic science in detecting diseases before symptoms arise. Innovative AI Solutions M42 has introduced several groundbreaking healthcare innovations: Med42: An open-source, large clinical language model AIRIS-TB: An AI-powered system capable of conducting 2,000 chest X-rays daily to combat tuberculosis—ten times the capacity of traditional methods AI in Endoscopy: Enhances the detection of abnormalities and early signs of cancer These technologies signify a leap in diagnostic efficiency and precision, paving the way for personalized care. Genomics and the UAE Genome Programme M42’s Omics Centre of Excellence is spearheading genomic research, including the UAE Genome Programme, which aims to advance precision medicine and proactive health management. These initiatives are crucial for identifying genetic predispositions to diseases, further strengthening the UAE’s position as a leader in genomics-driven preventive healthcare. Global Inspiration Al Nowais concluded by highlighting the UAE’s commitment to setting new global standards in healthcare. Through innovations in AI, genomic science, and cross-sector collaboration, the UAE is shaping a future where preventive medicine and sustainable healthcare become the norm, inspiring countries worldwide. Source: Business Standard Photo Credit: Business Standard

MediBuddy Launches BuddyCare to Revolutionize Cashless Healthcare

Leave a Comment / By / Health & Wellness Community

MediBuddy has unveiled BuddyCare, a networking platform under the India Health Care Collaborators (IHCC) initiative, to strengthen India’s cashless primary healthcare infrastructure. This innovative platform connects insurance companies, healthcare providers, and intermediaries, fostering a robust ecosystem in alignment with India’s ‘Insurance for All by 2047’ vision. BuddyCare offers comprehensive services for insurers, including pre-policy issuance, real-time risk quantification, and seamless post-policy health and wellness service delivery. By integrating advanced fraud-resilient systems like the ‘Sherlock’ Fraud Detection System, BuddyCare enhances transparency and efficiency in outpatient department (OPD) processes. Satish Kannan, Co-founder and CEO of MediBuddy, emphasized the platform’s significance, stating, “IHCC marks a transformative step in redefining healthcare delivery in India. By integrating innovation, collaboration, and quality, we aim to create a universally accessible, cashless, and insurance-integrated healthcare model.” With a network of over 100,000 doctors, IHCC bridges gaps between life, health, and wellness insurance. Leveraging AI-driven tools, the platform improves risk management and service delivery while offering medical consultations, diagnostics, medicine delivery, and concierge support. MediBuddy also extends its reach to Non-Resident Indians (NRIs), ensuring inclusive healthcare solutions. As part of its Corporate Social Responsibility (CSR) initiatives, the company runs paramedical training programs to bolster healthcare infrastructure nationwide. This initiative not only supports MediBuddy’s mission but also aligns with national policy objectives. By integrating technology and strategic partnerships, BuddyCare is set to redefine healthcare delivery across urban and rural India, ensuring greater accessibility, affordability, and efficiency. Source: expresshealthcare Photo Credit: expresshealthcare

Singapore’s Ministry of Health Commits SG$200 Million to AI-Driven Healthcare Innovations

Leave a Comment / By / Health & Wellness Community
Health news

The Singaporean Ministry of Health (MOH) has announced a significant investment of SG$200 million (approximately $150 million) over the next five years to enhance the implementation of AI technologies across the country’s healthcare system. This financial boost is part of the MOH Health Innovation Fund, aimed at advancing technological innovations and expanding AI integration into system-wide, national projects. Key Initiatives Supported by the Investment: Generative AI for Record Automation: A major focus of the funding will be a generative AI project designed to automate the updating of medical records. The MOH plans to roll out this project across the public healthcare system by the end of 2025, with the goal of streamlining administrative tasks such as documentation and the summarisation of medical records. AI in Medical Imaging: The MOH will also invest in medical imaging AI for early detection of breast cancer. This technology, currently undergoing validation, is expected to be adopted as part of a national subsidised screening programme by the end of 2025. The initiative will enhance early detection and diagnosis through advanced AI-assisted imaging tools. Broader Trends in Singapore’s AI-Driven Healthcare: Singapore’s healthcare system has been making strides in integrating AI and generative AI (genAI) technologies, backed by the government. The national health tech agency Synapxe has expanded its partnership with Microsoft, working on projects like Secure GPT for Healthcare Professionals, which develops large language models (LLMs) for healthcare applications. The National University Health System (NUHS) has also developed RUSSELL-GPT, an AI chatbot that summarises patient case notes and generates referral letters. Additionally, Singapore General Hospital is exploring genAI use in pre-surgery assessments, and hospitals under SingHealth have adopted chest X-ray analysis AI through AimSG, a national radiology AI platform. The platform, launched last year, allows hospitals to integrate validated AI tools into their workflows. Genetic Testing Programme: The MOH also announced plans to launch a national genetic testing programme by mid-2025, with a focus on Familial Hypercholesterolemia, a genetic condition affecting cholesterol levels. This marks another step towards incorporating advanced technology into personalised healthcare. Strengthening AI Governance: As AI becomes more central to Singapore’s healthcare system, the MOH is committed to improving national governance for AI use in healthcare. The ministry emphasized the need to balance innovation with safety, ensuring that new AI solutions are implemented securely and deliver safe care to patients. Conclusion: Singapore’s investment in AI-driven healthcare innovations demonstrates its forward-thinking approach to enhancing healthcare delivery. With a focus on automation, early detection, and improving overall patient care Source: Business Standard

South Korea Advances Medical Data Exchange and AI-Driven Healthcare Research

Leave a Comment / By / Health & Wellness Community

South Korea’s Ministry of Health and Welfare (MOHW) is making significant strides in improving medical data exchange as part of its broader mission to enhance the use of health data across hospitals. These efforts include the ongoing development of the Korea Core Data for Interoperability and Transmission standards, alongside the implementation of the digital health record platform MyHealthway, now in its second phase. In addition to these initiatives, South Korea is set to launch a national project this year aimed at integrating the biological data of nearly 800,000 individuals. This ambitious project seeks to enhance health research and innovation by providing a vast pool of biological and medical data for analysis. The MOHW, in collaboration with the Korea Health Information Service, is also working on data-sharing agreements with major hospitals to promote the use of medical data for research purposes. This project aims to foster better utilization of medical information to drive forward medical innovations and improve patient outcomes. In a further push for innovation, an MOHW-led committee recently unveiled a four-year roadmap for establishing a robust medical AI research and development ecosystem. The roadmap emphasizes the need to invest in AI for essential medical care, including emergency services, major diseases, cancer treatment, and the development of AI-powered digital therapeutics, surgical robots, and AI-driven drug discovery. A key component of this roadmap is the creation of a unified healthcare data platform to support ongoing medical AI research. The platform is expected to streamline collaboration among researchers, hospitals, and tech developers, positioning South Korea as a leader in medical AI and healthcare innovation. Source: healthcareitnews